Form 8-K - Current report:
SEC Accession No. 0001640334-24-001396
Filing Date
2024-09-05
Accepted
2024-09-05 10:11:19
Documents
18
Period of Report
2024-08-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K lxrp_8k.htm   iXBRL 8-K 35586
2 EX-99.1 lxrp_ex991.htm EX-99.1 25598
8 lxrp_ex991img2.jpg GRAPHIC 3004
9 lxrp_ex991img3.jpg GRAPHIC 44984
  Complete submission text file 0001640334-24-001396.txt   279879

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA lxrp-20240831.xsd EX-101.SCH 6120
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE lxrp-20240831_lab.xml EX-101.LAB 16213
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lxrp-20240831_cal.xml EX-101.CAL 898
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lxrp-20240831_pre.xml EX-101.PRE 11893
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lxrp-20240831_def.xml EX-101.DEF 4149
20 EXTRACTED XBRL INSTANCE DOCUMENT lxrp_8k_htm.xml XML 5583
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

EIN.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 001-39874 | Film No.: 241280258
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)